The DEA is expected to finalize on Wednesday the previously suggested Schedule II status for Syndros, the FDA-approved drug developed by Insys Therapeutics. Source: http://www.thecannabist.co/2017/11/21/dea-syndros-synthetic-thc-insys-schedule-ii/92862/ Tags: > 420News | #420, #news, #NewsDog, #TopNews, 420 | #News420, #LatestNews, News
Original Post: https://droolindog.net/2017/11/21/dea-finalizing-schedule-ii-status-for-synthetic-thc-drug-syndros/
Tuesday, November 21, 2017
DEA finalizing Schedule II status for synthetic THC drug Syndros | Droolin Dog dot Net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment